A method for preparing formoterol, its pharmaceutically acceptable salt and its intermediates
By performing the salt reaction, neutralization reaction and crystallization steps in an organic solvent, the preparation process of formoterol is simplified, and the problems of low purity of intermediates and final products in the prior art are solved, cumbersome in operation and use of harmful reagents. It realizes high purity and low cost formoterol preparation, suitable for industrial production.
Patent Information
- Application Number
- CN202111437905.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2018-11-28
- Publication Date
- 2024-11-05
- Estimated Expiration
- 2038-11-28
AI Technical Summary
The existing preparation methods formoterol have problems such as low purity of intermediates and final products, use of harmful reagents, cumbersome operation, high cost, and unsuitable production for industrialization.
Using a new preparation method, including purification of formoterol intermediate, purification of formoterol and preparation of formoterol fumarate, salt reaction, neutralization reaction and crystallization in an organic solvent Steps, simplify process flow, improve purity and yield, and avoid the use of dangerous reagents.
It realizes high purity preparation of formoterol intermediates and final products, reduces production costs, simplifies operating procedures, is suitable for industrial production, and does not use harmful reagents.
Smart Images

Figure CN113999134B_ABST
Abstract
Description
Field of the Invention
[0001] The invention belongs to the technical field of drug synthesis, and specifically relates to a preparation method of formoterol, its pharmaceutically acceptable salt and an intermediate thereof. Background Art
[0002] The chemical name of the pharmaceutically acceptable salt of formoterol (Formula I) is: {N-[2-hydroxy-5-[(RS)-1-hydroxy-2-[(RS)-2-(4-methoxyphenyl)-1-methylethylamino]ethyl]phenyl]}formamide fumarate dihydrate, which is a β2 sympathomimetic drug with long-acting, high selectivity, strong anti-inflammatory effect, rapid onset and mild side effects; it has the typical basic structure of all sympathomimetic drugs, and the substituents on the amino nitrogen make it highly selective for β2 receptors. Pharmacological studies have shown that formoterol fumaric acid dihydrate exerts anti-inflammatory effects and inhibits pulmonary edema by inhibiting multiple links in the pathological process of asthma and the release of inflammatory mediators. Clinical studies have shown that oral or inhaled formoterol can effectively control asthma (especially nocturnal asthma) attacks, and the effects can be maintained for more than 12 hours.
[0003]
[0004] The synthesis process of the pharmaceutically acceptable salt of formoterol (Formula I) is very complicated, and is reported in documents such as US3994974, ES2005492 and WO2008 / 035380A2. The European Pharmacopoeia 2005 monograph discloses the impurities and their limits of the pharmaceutically acceptable salt of formoterol (Formula I), as shown in the following table:
[0005]
[0006] The synthetic route disclosed in US3994974 is as follows:
[0007]
[0008] This method has the following disadvantages:
[0009] 1) The intermediates, final products and enantiomeric purity were not disclosed;
[0010] 2) Separation of unwanted isomers (RS, SR) at the late stage of synthesis, and the unwanted isomers cannot be recovered, resulting in increased costs and pollution.
[0011] The synthetic route disclosed in ES2005492 is as follows:
[0012]
[0013] This method has the following disadvantages:
[0014] 1) The synthesis process uses harmful reagents such as hydrofluoric acid and crown ethers and carcinogenic solvents such as benzene, which are expensive and rare substances and pose serious health and environmental problems, and are not suitable for scale-up operations.
[0015] 2) No quality information about formoterol fumarate is disclosed.
[0016] The synthetic route disclosed in WO2008 / 035380A2 is as follows:
[0017]
[0018] Through research, it was found that the method is applied in the reaction of preparing the pharmaceutically acceptable salt of formoterol (Formula I) and has the following problems:
[0019] 1) In the preparation process from the starting material to the compound of formula X, overnight grinding and multiple purifications are required, which is cumbersome. In addition, in the preparation and purification process of the compound of formula X, the activated carbon adsorption effect is not significant, resulting in difficulty in crystallization and incomplete crystallization, which seriously affects the yield of the compound of formula X.
[0020] 2) In the preparation process of the compound of formula VI, the reaction speed of formic acid is slow, the reaction is incomplete, and the yield after purification is low. When formic acid and acetic anhydride are used for the reaction, acetic anhydride will react with the compound of formula V to produce acetylated by-products (impurity C), which are not easy to remove, affecting the purity and yield of the compound of formula VI.
[0021] 3) In the entire preparation process of the final product, the compound of formula I, multiple crystallizations are used, high temperature conditions are used, and the operation is cumbersome. The compound of formula I is extremely unstable when heated at high temperature in a solvent, especially in an alcohol solvent, and impurities A and impurity F are generated. The purification effect is not significant, and the controllability of the production time is poor, and the ideal purification effect cannot be achieved.
[0022] 4) The final product of formula I is vacuum dried at 60° C., which is a high temperature and poses a risk of losing crystal water.
[0023] In summary, it is necessary to find a better method for preparing and purifying important intermediates V and compounds of formula VII so as to achieve higher yields and higher purities and be suitable for industrial production. Summary of the invention
[0024] In order to overcome the defects of the prior art, the object of the present invention is to provide a method for purifying formoterol, its pharmaceutically acceptable salts and important intermediates thereof which is simple to operate, high in purity, high in yield and suitable for commercial production.
[0025] In particular, it is an object of the present invention to provide an improved process for purifying the compound of formula V which allows efficient removal of diastereoisomers.
[0026] Another object of the present invention is to provide an improved process for the preparation of the compound of formula VI.
[0027] It is a further object of the present invention to provide an improved process for the purification of the compound of formula VII.
[0028] Another object of the present invention is to provide a method for preparing the compound of formula I, wherein the salt formation and purification are completed in one step, which is simple and efficient.
[0029] The above-mentioned purpose of the present invention is achieved by adopting the following technical solutions:
[0030] In one aspect, the present invention provides a method for purifying a formoterol intermediate (a compound represented by formula V), the method comprising the following steps:
[0031]
[0032] I) allowing a crude compound of formula V and fumaric acid to undergo a salt-forming reaction in an organic solvent A to prepare a fumarate of the compound of formula V;
[0033] II) neutralizing the fumarate of the compound represented by formula V obtained in step I) with a base in an organic solvent B to obtain a purified compound represented by formula V;
[0034] III) crystallizing the purified compound of formula V obtained in step II) in an organic solvent C to obtain a formoterol intermediate.
[0035] Preferably, in step I), the organic solvent A is an ester and an alcohol, preferably ethyl acetate and an alcohol, more preferably ethyl acetate and a lower alkanol (such as methanol, ethanol).
[0036] Preferably, in step I), the preparation method of the fumarate salt of the compound represented by formula V is as follows:
[0037] Heat the crude compound of formula V and ethyl acetate to 60-75°C, then add fumaric acid and alcohol, stir to dissolve, and after complete dissolution, cool to 20-35°C, stir for 1-2h, and then continue to cool to -10-20°C, stir and crystallize for 1-2h to obtain;
[0038] Preferably, in step I), the preparation method of the fumarate salt of the compound represented by formula V is as follows:
[0039] Heat the crude compound of formula V and ethyl acetate to 70-75°C, then add fumaric acid and alcohol, stir to dissolve, and after complete dissolution, cool to 20-30°C, stir for 1-2h, continue to cool to 0-10°C, stir and crystallize for 1-2h to obtain the product.
[0040] Preferably, in step I), the alcohol in the organic solvent A is selected from one or more of methanol, ethanol and isopropanol, preferably methanol or ethanol, more preferably methanol.
[0041] Preferably, in step II), the preparation method of the purified compound represented by formula V is as follows:
[0042] The fumarate of the compound represented by formula V obtained in step I) and a base are heated in an organic solvent B to an internal temperature of 20-40° C., and stirred for reaction for 4-6 hours to obtain;
[0043] Preferably, in step II), the preparation method of the purified compound represented by formula V is as follows:
[0044] The fumarate of the compound represented by formula V obtained in step I) and a base are heated in an organic solvent B to an internal temperature of 30-40° C. and stirred for reaction for 4-6 hours to obtain the product.
[0045] Preferably, in step II), the organic solvent B is ethyl acetate, acetonitrile or dichloromethane, preferably dichloromethane or ethyl acetate, more preferably dichloromethane.
[0046] Preferably, in step II), the base is a 10 w / v%-20 w / v% sodium carbonate solution or a 10 w / v%-20 w / v% potassium carbonate solution, preferably a 10 w / v%-20 w / v% sodium carbonate solution, more preferably a 10 w / v% sodium carbonate solution.
[0047] Preferably, in step III), the preparation method of the formoterol intermediate is as follows:
[0048] The purified compound of formula V obtained in step II) is heated to 50-70° C. in an organic solvent C, stirred to dissolve, and after being completely dissolved, the internal temperature is slowly lowered to 15-35° C., stirred and crystallized for 2-3 hours, thereby obtaining a formoterol intermediate;
[0049] Preferably, in step III), the preparation method of the formoterol intermediate is as follows:
[0050] The purified compound of formula V obtained in step II) is heated to 60-70° C. in an organic solvent C, stirred and dissolved, and after being completely dissolved, the internal temperature is slowly lowered to 20-30° C., stirred and crystallized for 2-3 hours to obtain a formoterol intermediate.
[0051] Preferably, in step III), the organic solvent C is 50 v / v% ethanol, ethyl acetate or isopropyl ether, preferably 50 v / v% ethanol or isopropyl ether, more preferably isopropyl ether.
[0052] Preferably, in step III), the ratio between the purified compound of formula V obtained in step II) and the organic solvent C is 1 g:8.0 mL-1 g:15.0 mL, preferably 1 g:10.0 mL-1 g:12.0 mL.
[0053] Preferably, the method for preparing the crude compound represented by formula V comprises the following steps:
[0054] 1) allowing the compound represented by formula II and the compound represented by formula III to undergo condensation reaction to obtain the compound represented by formula IV;
[0055]
[0056] 2) subjecting the compound represented by formula IV to a reduction reaction in the presence of reduced iron powder, ammonium chloride, anhydrous ethanol and water to obtain a crude compound represented by formula V;
[0057]
[0058] In another aspect, the present invention provides a method for purifying formoterol (a compound represented by formula VII), the method comprising the following steps:
[0059]
[0060] 1) Pressing out the crude formoterol with nitrogen, filtering, and washing with an organic solvent D;
[0061] 2) concentrating and evaporating the filtrate obtained in step 1) under reduced pressure;
[0062] 3) adding organic solvent E and organic solvent F to the product obtained by evaporation in step 2), stirring and slurrying to obtain formoterol.
[0063] Preferably, in step 1), the organic solvent D is a mixed solution of methanol and ethyl acetate, methanol, ethanol or tetrahydrofuran, preferably a mixed solution of methanol and ethyl acetate.
[0064] Preferably, in step 2), the reduced pressure concentration and evaporation is carried out in a water bath at 30-40°C, preferably in a water bath at 30-35°C.
[0065] Preferably, in step 3), the organic solvent E is dichloromethane, 1,2-dichloroethane or chloroform, preferably dichloromethane;
[0066] Preferably, in step 3), the organic solvent F is methanol, ethanol or isopropanol, preferably methanol;
[0067] Preferably, in step 3), the volume ratio between the organic solvent E and the organic solvent F is 20:1-30:1, preferably 25:1-30:1.
[0068] Preferably, in step 1), the method for preparing the crude formoterol comprises the following steps:
[0069] i) subjecting the compound represented by formula V and anhydrous formic acid to a formylation reaction in the presence of a condensing agent and an organic solvent G, followed by crystallization to obtain a compound represented by formula VI;
[0070]
[0071] ii) subjecting the compound represented by formula VI to a reduction reaction in the presence of a catalyst and an organic solvent H to obtain a crude formoterol product (formoterol reaction solution);
[0072]
[0073] Preferably, in step i), the condensing agent is 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDCI), 2-(7-benzotriazole oxide)-N,N,N',N'-tetramethyluronium hexafluorophosphate (HATU) or dicyclohexylcarbodiimide (DCC), preferably EDCI;
[0074] Preferably, in step i), the organic solvent G is selected from one or more of dichloromethane, 1,2-dichloroethane, chloroform and ethyl acetate, preferably dichloromethane or 1,2-dichloroethane, more preferably dichloromethane;
[0075] Preferably, in step ii), the catalyst is 5w / w%-10w / w% palladium carbon or Raney nickel, preferably 5w / w%-10w / w% palladium carbon, more preferably 10w / w% palladium carbon;
[0076] Preferably, in step ii), the organic solvent H is a mixed solution of methanol and ethyl acetate, methanol, ethanol or tetrahydrofuran, preferably a mixed solution of methanol and ethyl acetate.
[0077] Preferably, in step i), the compound represented by formula V is a formoterol intermediate prepared by the aforementioned purification method.
[0078] In another aspect, the present invention provides a method for preparing formoterol fumarate (the compound shown in Formula I), the method comprising the following steps:
[0079] The compound represented by formula VII and fumaric acid undergo salt-forming reaction in the presence of methanol, dimethyl sulfoxide (DMSO), organic solvent I and water, and then crystallize to obtain the product.
[0080] Preferably, the organic solvent I is acetone, dichloromethane, butanone, ethyl acetate or acetonitrile, preferably butanone, ethyl acetate or acetonitrile, most preferably butanone.
[0081] Preferably, the compound represented by formula VII is formoterol prepared by the aforementioned purification method.
[0082] In one specific embodiment, the reaction route of the preparation method of formoterol fumarate (the compound shown in Formula I) is as follows:
[0083]
[0084] Compared with the prior art, the preparation method disclosed in the present invention has a short route, is simple and feasible, can greatly reduce production costs, does not involve the use of dangerous or seriously toxic reagents, and ultimately produces a high-purity (RR, SS ≥ 99.8%, RS, SR ≤ 0.05%) target compound, which is suitable for industrial production applications. BRIEF DESCRIPTION OF THE DRAWINGS
[0085] The embodiments of the present invention are described in detail below with reference to the accompanying drawings, wherein
[0086] Figure 1 is the 1H-NMR spectrum of formoterol fumarate;
[0087] Figure 2 is the HPLC spectrum of impurity A and formoterol fumarate;
[0088] Figure 3 is the HPLC spectrum of impurity I and formoterol fumarate;
[0089] Figure 4 It is the system suitability spectrum of impurity I and formoterol fumarate. DETAILED DESCRIPTION
[0090] The following is a detailed description of embodiments of the present invention, but the present invention can be implemented in many different ways as defined and covered by the claims.
[0091] Example 1
[0092] 1) Add the compound of formula II (178.1 g) and the compound of formula III (161.7 g) to a reaction bottle, stir, heat to an internal temperature of 90-100°C, react for 2-3 h, and then to an internal temperature of 120-130°C, and react for 2-3 h until complete (HPLC detection, calculated by normalization method based on the peak area, the reaction is considered complete if the compound of formula III in the test sample is less than 10%) to obtain 320.5 g of compound IV, cool to 70±5°C, and add anhydrous ethanol (220 mL) to dissolve in preparation for the next step.
[0093]
[0094] 2) Add the compound of formula IV (220 mL) dissolved in anhydrous ethanol and anhydrous ethanol (1280 mL) to the reaction flask, stir, add reduced iron powder (199.7 g), wash the residue with anhydrous ethanol (1000 mL), then add ammonium chloride (191.3 g) and water (440 mL), heat to an internal temperature of 75-85°C, react for 2-3 h until complete (HPLC detection, calculated by normalization method based on peak area, the reaction is considered complete when the compound of formula IV in the test sample is less than 5.0%), then cool to 75±1°C, add ethyl acetate, stir and cool to 20-30°C, then add ethyl acetate (550 mL) for washing, filter, combine all the filtrates, and then concentrate the obtained filtrate under reduced pressure at 50-60°C to dryness to remove ethyl acetate and ethanol, then add ethyl acetate (1650 mL) and water (1100 mL), stir, separate and remove the water layer. The organic phase was washed once with a 10% aqueous sodium carbonate solution (1100 mL), then washed once with a 20% aqueous sodium chloride solution (1100 mL), stirred with anhydrous magnesium sulfate (220 g) and activated carbon (22 g) for 1-2 h, filtered to remove the desiccant, washed three times with ethyl acetate (220 mL), concentrated and dried under reduced pressure at 50-60° C. to obtain a reddish brown viscous substance, which was 296 g of compound V (A). Purity: 57.92%, diastereoisomers: 40.65%.
[0095]
[0096] 3) Step a): Add the compound of formula V (A) (280 g) and ethyl acetate (500 mL) to a reaction flask, stir and dissolve, then add ethyl acetate (340 mL), stir, heat to an internal temperature of 60-65°C, add fumaric acid (32.7 g) and methanol (210 mL), until the viscous material is completely dissolved, then cool to 40°C at a rate of 10°C per hour, then cool to 20-30°C in a water bath, stir for 1-2 h, cool to an internal temperature of -10-0°C, stir and crystallize for 1-2 h, filter to obtain a solid, wash with ethyl acetate until the filtrate is light yellow, and then vacuum dry at 50±5°C for 4-6 h to obtain 190 g of a light yellow solid.
[0097] Step b): Add the light yellow solid (130 g) obtained in step a), dichloromethane (650 mL) and 10% aqueous sodium carbonate solution (650 mL) into a reaction flask, heat to an internal temperature of 20-30°C to generate a large amount of gas, stir for 4-6 h until the solid completely disappears, let stand, separate the liquids, extract the aqueous layer with dichloromethane (325 mL) once, combine the organic phases, wash the organic phases with 20% aqueous sodium chloride solution (650 mL), wash twice, and then concentrate under reduced pressure at 40-50°C to remove the solvent to obtain 116 g of a yellow oil.
[0098] Step c): Add the yellow oil (115 g) obtained in step b) and 50% ethanol (920 mL) to a reaction flask, heat to 50-60°C, stir to dissolve, and slowly lower the internal temperature to 15-20°C after complete dissolution. Keep the internal temperature at 15-20°C, stir to crystallize for 2-3 h, filter to obtain a solid, wash the solid three times with 50% ethanol (115 mL), and then vacuum dry at 50±5°C for 4-6 h to obtain 94.2 g of compound V as a white solid, with a yield of 81.91%, a purity of 99.91%, and a diastereoisomer of 0.04%.
[0099]
[0100] 4) Add the compound of formula V (65 g) and 1,2-dichloroethane (300 mL) to the reaction flask, cool the reaction solution to 0-10°C under N2 conditions, then add 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDCI) (44.9 g) and 1,2-dichloroethane (25 mL), slowly dropwise add anhydrous formic acid (12.0 g) at an internal temperature of 0-10°C, after the addition is complete, keep the internal temperature at 0-10°C, react for 1-2 hours, until the reaction is complete (HPLC detection, calculated by normalization method based on peak area, the reaction is considered complete when the compound of formula V in the test sample is less than 0.50%. Then turn off the cooling device, add 10% sodium carbonate aqueous solution (275 mL), raise the temperature to 20-30°C, stir for 0.5-1.0 hours, and separate the organic layer The aqueous layer was extracted with 1,2-dichloroethane (275 mL), and then combined with the 1,2-dichloroethane layer, and washed with 10% sodium carbonate aqueous solution (275 mL) under stirring for 0.5-1.0 h, and then washed twice with 20% sodium chloride aqueous solution (325 mL). The organic phase was concentrated under reduced pressure at 40-50 ° C to obtain a reddish brown viscous substance as a crude compound of formula VI. 325 mL of methanol was added, and the mixture was heated at 40-50 ° C with stirring. After the solid was dissolved, the temperature was reduced to 0-10 ° C, stirred for 1-2 h, and filtered to obtain a solid. The solid was washed twice with 0-10 ° C methanol (65 mL), and then vacuum dried at 45±5 ° C for 4-8 h to obtain a white solid as 56.2 g of compound VI, with a yield of 81.84%, a purity of 99.94%, and a non-corresponding isomer: 0.02%.
[0101]
[0102] 5) Add the compound of formula VI (60 g), 5% palladium on carbon (12.0 g), and tetrahydrofuran (720 mL) to the reaction flask, start stirring, and release nitrogen into the hydrogenation kettle three times, each time until the pressure reaches 0.50-0.52 MPa, and then release hydrogen into the hydrogenation kettle three times, each time until the pressure reaches 0.50-0.52 MPa. Heat to 30-35° C. under the condition of hydrogen pressure of 0.50-0.52 MPa, and stir for 4-5 h until the reaction is complete (HPLC detection, calculated by normalization method based on peak area, impurity H <1.0%, the reaction can be considered complete), then remove the pressure, replace once with nitrogen 0.2-0.3 MPa, press out the reaction solution with nitrogen, filter, wash the reaction flask and filter cake with tetrahydrofuran (300 mL), and concentrate the filtrate under reduced pressure and evaporate in a water bath at 30-35° C. for less than 4 h, and the vacuum degree is greater than -0.09MPa, then add dichloromethane (300mL) and methanol (10mL) with stirring, slurry at 20-30°C for 3-4h, filter to obtain a solid, wash the solid with dichloromethane (60mL) 3 times, and vacuum dry at 40±5°C for 4-6h to obtain 32.2g of a white solid of compound of formula VII, with a yield of 81.75%, a purity of 99.93%, diastereoisomers of 0.02%, impurity A of 0.02%, and impurities B, C, D, E, F, G, and H were not detected.
[0103]
[0104] 6) Add the compound of formula VII (25 g), methanol (375 mL) and dimethyl sulfoxide (DMSO) (50 mL) to a reaction flask, add fumaric acid (4.2 g) and methanol (125 mL) at 20-30 ° C, stir to dissolve, stir for 10 min after the solid is dissolved, add water (50 mL) and butanone (500 mL), cool to 0-10 ° C, stir for 2-3 h at 0-10 ° C after solid precipitation, filter, rinse the solid with butanone (75 mL) 3 times, and then vacuum dry at 40 ± 5 ° C for 4-6 h to obtain a white solid as the compound of formula I 25.5 g, yield: 83.68%, purity: 99.95%, diastereoisomer: 0.02%, impurity A: 0.01% (correction factor 1.75), impurities B, C, D, E, F, G, H were not detected.
[0105] The measured spectral data of the compound of formula I are as follows:
[0106] 1H-NMR(d6-DMSO)δ(ppm): 0.994(d,6H,J=6.36Hz), 2.498(m,2H), 2.817(dd,2H,J=9.3&1 2Hz), 2.872(dd,2H,J=3.4&12Hz), 2.918(dd,2H,J=4.4&13.2Hz), 3.115(m,2H), 3.719(s , 6H), 4.673 (dd, 2H, J = 3.6 & 9 Hz), 6.493 (s, 2H), 6.845 (m, 4H), 6.857 (m, 2H), 6.912 (m, 2H), 7.098 (m, 4H), 8.084 (m, 2H), 8.285 (m, 2H), 9.619 (s, 2H). The above spectral data prove that the compound of formula 1 is formoterol fumarate, see Figure 1 .
[0107] Example 2
[0108] 1) Add the compound V(A) (280 g) obtained in step 2) of Example 1 and ethyl acetate (500 mL) to a reaction flask, stir and dissolve, then add ethyl acetate (340 mL), stir, heat to an internal temperature of 65-70°C, add fumaric acid (32.7 g) and ethanol (210 mL) until the viscous substance is completely dissolved, then cool to 40°C at a rate of 10°C per hour, then cool to 30-35°C in a water bath, stir for 1-2 h, cool to an internal temperature of 0-10°C, stir and crystallize for 1-2 h, filter to obtain a solid, wash with ethyl acetate until the filtrate is light yellow, and then vacuum dry at 50±5°C for 4-6 h to obtain 190 g of a light yellow solid.
[0109] The light yellow solid (130 g) obtained in the previous step, ethyl acetate (650 mL) and 15% aqueous sodium carbonate solution (650 mL) were added to the reaction flask, heated to an internal temperature of 30-40°C to generate a large amount of gas, stirred for 4-6 hours until the solid completely disappeared, allowed to stand, separated, the aqueous layer was extracted once with ethyl acetate (325 mL), the organic phases were combined, washed twice with 20% aqueous sodium chloride solution (650 mL), and then concentrated under reduced pressure at 40-50°C to remove the solvent to obtain 116 g of a yellow oil.
[0110] The yellow oil (115 g) obtained in the previous step and ethyl acetate (1150 mL) were added to the reaction flask, heated to 60-70°C, stirred to dissolve, and after complete dissolution, slowly lowered to an internal temperature of 20-25°C, maintained at an internal temperature of 20-25°C, stirred for crystallization for 2-3 h, filtered to obtain a solid, washed three times with ethyl acetate (115 mL), and then vacuum dried at 50±5°C for 4-6 h to obtain a white solid as compound V (94.8 g), with a yield of 82.43%, a purity of 99.82%, and a diastereoisomer of 0.02%.
[0111] 2) Add the compound of formula V (65 g) and chloroform (300 mL) to a reaction flask, cool the reaction solution to 0-10°C under N2 conditions, then add 2-(7-benzotriazole oxide)-N,N,N',N'-tetramethyluronium hexafluorophosphate (HATU) (89.1 g) and chloroform (25 mL), slowly dropwise add anhydrous formic acid (12.0 g) at an internal temperature of 0-10°C, after the addition is complete, keep the internal temperature at 0-10°C, react for 1-2 h, until the reaction is complete (HPLC detection, calculated by normalization method based on peak area, the reaction is considered complete when the compound of formula V in the test sample is less than 0.50%. Then turn off the cooling device, add 10% sodium carbonate aqueous solution (275 mL), raise the temperature to 20-30°C, stir for 0.5-1.0 h, The organic layer was separated, and the aqueous layer was extracted with chloroform (275 mL), then combined with the chloroform layer, washed with 10% aqueous sodium carbonate solution (275 mL) under stirring for 0.5-1.0 h, and then washed twice with 20% aqueous sodium chloride solution (325 mL). The organic phase was concentrated under reduced pressure at 40-50° C. to obtain a reddish-brown viscous substance as a crude compound of formula VI. 325 mL of methanol was added, and the mixture was heated at 40-50° C. with stirring. After the solid was dissolved, the temperature was lowered to 0-10° C. and stirred for 1-2 h. The solid was filtered to obtain a solid. The solid was washed twice with methanol (65 mL) at 0-10° C., and then vacuum dried at 45±5° C. for 4-8 h to obtain 56.6 g of a white solid as a compound of formula VI with a yield of 82.42%, a purity of 99.86%, and 0.05% of diastereoisomers.
[0112] 3) Add the compound of formula VI (60 g), 10% palladium on carbon (12.0 g), methanol (360 mL) and ethyl acetate (360 mL) to the reaction flask, start stirring, release nitrogen into the hydrogenation kettle three times, each time until the pressure reaches 0.50-0.52 MPa, and then release hydrogen into the hydrogenation kettle three times, each time until the pressure reaches 0.50-0.52 MPa. Heat to 30-35°C under the condition of hydrogen pressure of 0.50-0.52 MPa, stir for 4-5 hours until the reaction is complete (HPLC detection, calculated by normalization method based on peak area, impurity H <1.0%, the reaction is considered complete), then remove the pressure, replace once with nitrogen 0.2-0.3 MPa, press out the reaction solution with nitrogen, filter, wash the reaction flask and filter cake with a mixed solution of methanol (150 mL) and ethyl acetate (150 mL), and concentrate the filtrate under reduced pressure and evaporate in a water bath at 35-40°C for less than 4 hours, and vacuum The temperature was set to -0.09 MPa, 1,2-dichloroethane (300 mL) and methanol (12 mL) were added, stirred, slurried at 20-30 ° C for 3-4 h, filtered to obtain a solid, washed three times with 1,2-dichloroethane (60 mL), and dried in vacuo at 40±50 ° C for 4-6 h to obtain 32.5 g of a white solid compound of formula VII, with a yield of 82.52%, a purity of 99.89%, diastereoisomers of 0.05%, impurity A of 0.02%, and impurities B, C, D, E, F, G, and H were not detected.
[0113] Example 3
[0114] 1) Add high-purity compound V (65 g) and ethyl acetate (300 mL) to a reaction flask, cool the reaction solution to 0-10°C under N2 conditions, then add dicyclohexylcarbodiimide (DCC) (62.3 g) and ethyl acetate (25 mL), slowly dropwise add anhydrous formic acid (12.0 g) at an internal temperature of 0-10°C, and after the addition is complete, keep the internal temperature at 0-10°C for 1-2 h until the reaction is complete (HPLC detection, calculated by normalization method based on peak area, the reaction is considered complete when the compound V in the test sample is less than 0.50%.), then turn off the cooling device, add 10% sodium carbonate aqueous solution (275 mL), raise the temperature to 20-30°C, stir for 0.5-1.0 h, separate the organic layer, and use acetic acid to remove the aqueous layer. The mixture was extracted with ethyl ester (275 mL), and then combined with the ethyl acetate layer, washed with 10% aqueous sodium carbonate solution (275 mL) under stirring for 0.5-1.0 h, and then washed twice with 20% aqueous sodium chloride solution (325 mL). The organic phase was concentrated under reduced pressure at 40-50 ° C to obtain a reddish-brown viscous substance as a crude compound of formula VI. 325 mL of methanol was added, and the mixture was heated at 40-50 ° C with stirring. After the solid was dissolved, the temperature was reduced to 0-10 ° C, stirred for 1-2 h, and filtered to obtain a solid. The solid was washed twice with 0-10 ° C methanol (65 mL), and then vacuum dried at 45±5 ° C for 4-8 h to obtain 55.99 g of a white solid as a compound of formula VI, with a yield of 81.53%, a purity of 99.91%, and a non-corresponding isomer: 0.04%.
[0115] 2) Add the compound of formula VI (60 g), Raney nickel (12.0 g), and tetrahydrofuran (720 mL) to the reaction flask, start stirring, and release nitrogen into the hydrogenation kettle three times, each time until the pressure reaches 0.50-0.52 MPa, and then release hydrogen into the hydrogenation kettle three times, each time until the pressure reaches 0.50-0.52 MPa. Heat to 30-35°C under the condition of hydrogen pressure of 0.50-0.52 MPa, and stir for 4-5 hours until the reaction is complete (HPLC detection, calculated by normalization method based on peak area, impurity H <1.0%, the reaction can be considered complete), then remove the pressure, replace it with nitrogen 0.2-0.3 MPa once, press out the reaction solution with nitrogen, filter, wash the reaction flask and filter cake with tetrahydrofuran (300 mL), and concentrate the filtrate under reduced pressure and evaporate in a 35°C water bath for less than 4 hours, with a vacuum degree of 1.5. At -0.09 MPa, chloroform (300 mL) and methanol (12 mL) were added with stirring, and slurry was performed at 20-30 ° C for 3-4 h. The solid was filtered to obtain a solid, and the solid was washed 3 times with chloroform (60 mL). It was vacuum dried at 40±5 ° C for 4-6 h to obtain a white solid of formula VII (32.1 g). The yield was 81.50%, the purity was 99.91%, the diastereomer was 0.03%, the impurity A was 0.02%, and the impurities B, C, D, E, F, G, and H were not detected.
[0116] Example 4
[0117] 1) The compound of formula V (A) (280 g) obtained in step 2) of Example 1 and ethyl acetate (500 mL) were added to a reaction flask, stirred and dissolved, and then ethyl acetate (340 mL) was added, stirred, and heated to an internal temperature of 70-75°C, fumaric acid (32.7 g) and ethanol (210 mL) were added until the viscous material was completely dissolved, and then cooled to 40°C at a rate of 10°C per hour, and then cooled to 20-30°C in a water bath, stirred for 1-2 h, cooled to an internal temperature of 10-20°C, stirred for crystallization for 1-2 h, filtered to obtain a solid, and then washed with ethyl acetate until the filtrate was light yellow, and then vacuum dried at 50±5°C for 4-6 h to obtain 190 g of a light yellow solid.
[0118] 2) The light yellow solid (130 g) obtained in the previous step, acetonitrile (650 mL) and 20% potassium carbonate aqueous solution (650 mL) were added to the reaction flask, heated to an internal temperature of 30-40°C to generate a large amount of gas, stirred for 4-6 h until the solid completely disappeared, allowed to stand, separated, the aqueous layer was extracted once with acetonitrile (325 mL), the organic phases were combined, washed twice with 20% sodium chloride aqueous solution (650 mL), and then concentrated under reduced pressure at 40-50°C to remove the solvent to obtain 116 g of a yellow oil.
[0119] 3) The yellow oil (115 g) obtained in the previous step and isopropyl ether (1380 mL) were added to a reaction flask, heated to 60-70 ° C, stirred to dissolve, and after complete dissolution, slowly lowered to an internal temperature of 25-30 ° C, maintained at an internal temperature of 25-30 ° C, stirred for crystallization for 2-3 h, filtered to obtain a solid, washed three times with isopropyl ether (115 mL), and then vacuum dried at 50 ± 5 ° C for 4-6 h to obtain a white solid as a compound of formula V 93.8 g, yield: 81.57%, purity: 99.89%, diastereoisomer: 0.03%.
[0120] Example 5
[0121] The compound of formula VI (60 g) obtained in step 4) of Example 1, 10% palladium on carbon (12.0 g), and ethanol (720 mL) were added to the reaction flask, and stirring was started. Nitrogen was introduced into the hydrogenation kettle three times, each time until the pressure reached 0.50-0.52 MPa, and hydrogen was introduced into the hydrogenation kettle three times, each time until the pressure reached 0.50-0.52 MPa. Under the condition of introducing hydrogen to a pressure of 0.50-0.52 MPa, the mixture was heated to 30-35°C and stirred for 4-5 h until the reaction was complete (HPLC detection, calculated by normalization method based on peak area, impurity H <1.0%, the reaction was considered complete), and the pressure was removed, and the mixture was replaced once with nitrogen 0.2-0.3 MPa, the reaction solution was pressed out with nitrogen, filtered, and the reaction flask and filter cake were washed with ethanol (300 mL). The filtrate was concentrated and evaporated under reduced pressure in a water bath at 30-35°C for less than 4 h, and the vacuum degree was greater than - 0.09MPa, then add dichloromethane (300mL) and methanol (15mL) with stirring, slurry at 20-30℃ for 3-4h, filter to get a solid, wash the solid with dichloromethane (60mL) 3 times, and vacuum dry at 40±5℃ for 4-6h to get 32.0g of compound of formula VII as a white solid, with a yield of 81.25%, a purity of 99.92%, diastereoisomers of 0.02%, impurity A of 0.02%, and impurities B, C, D, E, F, G, and H were not detected.
[0122] Example 6
[0123] 1) Add the compound of formula II (1424.8 g) and the compound of formula III (1336.8 g) to a reaction flask, stir, heat to an internal temperature of 90-100°C, react for 2-3 h, and then to an internal temperature of 120-130°C, and react for 2-3 h until complete (HPLC detection, calculated by normalization method based on the peak area, the reaction is considered complete if the compound of formula III in the test sample is less than 10%.) to obtain 2480.2 g of the compound of formula IV, cool to 70±5°C, and add anhydrous ethanol (1760 mL) to dissolve for the next reaction.
[0124] 2) Add the compound of formula IV (1760 mL) dissolved in anhydrous ethanol and anhydrous ethanol (10240 mL) to the reaction flask, stir, add reduced iron powder (1597.6 g), wash the residue with anhydrous ethanol (8000 mL), then add ammonium chloride (1530.4 g) and water (3520 mL), heat to an internal temperature of 75-85°C, and react for 2-3 hours until complete (HPLC detection, calculated by normalization method based on peak area, the reaction is considered complete when the compound of formula IV in the test sample is less than 5.0%.) Then cool to 75±1°C, add ethyl acetate, stir and cool to 20-30°C, then add ethyl acetate (4400 mL) for washing, filter, combine all the filtrates, and then concentrate the obtained filtrate under reduced pressure at 50-60°C to dryness to remove ethyl acetate and ethanol, then add ethyl acetate (13200 mL) and water (8800 mL), stir, separate and remove the water layer. The organic phase was washed once with 10% sodium carbonate aqueous solution (8800 mL), then washed once with 20% sodium chloride aqueous solution (8800 mL), stirred with anhydrous magnesium sulfate (1760 g) and activated carbon (176 g) for 1-2 h, filtered to remove the desiccant, washed three times with ethyl acetate (1760 mL), concentrated and dried under reduced pressure at 50-60° C. to obtain a reddish brown viscous substance, which was 2350.5 g of compound V (A). Purity: 59.92%, diastereoisomers: 32.65%.
[0125] 3) Add the compound of formula V (A) (2240 g) and ethyl acetate (4000 mL) to the reaction flask, stir and dissolve, then add ethyl acetate (2720 mL), stir, heat to an internal temperature of 70-75 ° C, add fumaric acid (261.6 g) and isopropanol (1680 mL) until the viscous material is completely dissolved, then cool to 40 ° C at a rate of 10 ° C per hour, then cool to 20-30 ° C in a water bath, stir for 1-2 h, cool to an internal temperature of 0-10 ° C, stir and crystallize for 1-2 h, filter to obtain a solid, wash with ethyl acetate until the filtrate is light yellow, and then vacuum dry at 50 ± 5 ° C for 4-6 h to obtain 1480.1 g of a light yellow solid.
[0126] The light yellow solid (1040 g) obtained in the previous step, dichloromethane (5200 mL) and 10% potassium carbonate aqueous solution (5200 mL) were added to the reaction flask, heated to an internal temperature of 30-40°C to generate a large amount of gas, stirred for 4-6 hours until the solid completely disappeared, allowed to stand, separated, the aqueous layer was extracted once with dichloromethane (2600 mL), the organic phases were combined, washed twice with 20% sodium chloride aqueous solution (5200 mL), and then concentrated under reduced pressure at 40-50°C to remove the solvent to obtain 928.6 g of a yellow oil.
[0127] The yellow oil (920 g) obtained in the previous step and isopropyl ether (13800 mL) were added to the reaction flask, heated to 60-70°C, stirred to dissolve, and after complete dissolution, the internal temperature was slowly lowered to 30-35°C, maintained at 30-35°C, stirred for crystallization for 2-3 h, filtered to obtain a solid, washed three times with isopropyl ether (920 mL), and then vacuum dried at 50±5°C for 4-6 h to obtain 710.4 g of compound V as a white solid, with a yield of 77.17%, a purity of 99.90%, and a diastereoisomer of 0.04%.
[0128] 4) Add the compound of formula V (520 g) and dichloromethane (2400 mL) to the reaction flask, cool the reaction solution to 0-10°C under N2 conditions, then add 2-(7-benzotriazole oxide)-N,N,N',N'-tetramethyluronium hexafluorophosphate (HATU) (359.2 g) and dichloromethane (200 mL), slowly dropwise add anhydrous formic acid (96.0 g) at an internal temperature of 0-10°C, after the addition is complete, keep the internal temperature at 0-10°C, react for 1-2 hours, until the reaction is complete (HPLC detection, calculated by normalization method based on the peak area, the compound of formula V in the test sample is less than 0.50%, the reaction is considered complete.), then turn off the cooling equipment, add 10% sodium carbonate aqueous solution (2200 mL), raise the temperature to 20-30°C, stir Stir for 0.5-1.0h, separate the organic layer, extract the aqueous layer with dichloromethane (2200mL), combine with the dichloromethane layer, stir and wash with 10% sodium carbonate aqueous solution (2200mL) for 0.5-1.0h, and then wash twice with 20% sodium chloride aqueous solution (2600mL). The organic phase is concentrated under reduced pressure at 40-50°C to obtain a reddish brown viscous substance as a crude compound of formula VI. Methanol (2600mL) is added, heated at 40-50°C and stirred. After the solid is dissolved, the temperature is reduced to 0-10°C, stirred for 1-2h, and filtered to obtain a solid. The solid is washed twice with 0-10°C methanol (520mL), and then vacuum dried at 45±5°C for 4-8h to obtain a white solid as 446.3g of compound of formula VI, with a yield of 81.25%. Purity: 99.91%, non-corresponding isomers: 0.02%.
[0129] 5) Add the compound of formula VI (480 g), 10% palladium on carbon (96.0 g), methanol (2880 mL) and ethyl acetate (2880 mL) to the reaction flask, start stirring, and pass nitrogen into the hydrogenation kettle three times, each time until the pressure reaches 0.50-0.52 MPa, and then pass hydrogen into the hydrogenation kettle three times, each time until the pressure reaches 0.50-0.52 MPa. Under the condition of hydrogen gas passing to a pressure of 0.50-0.52 MPa, heat to 30-35°C, stir for 4-5 hours until the reaction is complete (HPLC detection, calculated by the normalized peak area, impurity H <1.0%, the reaction is considered complete), then remove the pressure, replace once with nitrogen gas 0.2-0.3 MPa, press out the reaction liquid with nitrogen, filter, wash the reaction bottle and filter cake with a mixed solution of methanol (1200 mL) and ethyl acetate (1200 mL), and concentrate the filtrate under reduced pressure and evaporate in a water bath at 30-35°C for less than 4 hours. The vacuum degree was greater than -0.09 MPa, and 1,2-dichloroethane (2400 mL) and ethanol (96 mL) were added with stirring. The mixture was slurried at 20-30 ° C for 3-4 h, and the solid was filtered to obtain a solid. The solid was washed three times with dichloromethane (480 mL) and dried in vacuo at 40±5 ° C for 4-6 h to obtain 269.4 g of a white solid of compound VII. The yield was 85.51%, the purity was 99.92%, the diastereomer was 0.03%, the impurity A was 0.02%, and the impurities B, C, D, E, F, G, and H were not detected.
[0130] 6) Add the compound of formula VII (200 g), methanol (3000 mL) and dimethyl sulfoxide (DMSO) (400 mL) to a reaction flask, add fumaric acid (33.6 g) and methanol (1000 mL) at 20-30 ° C, stir to dissolve, stir for 10 min after the solid is dissolved, add water (400 mL) and ethyl acetate (4000 mL), cool to 0-10 ° C, stir for 2-3 h at 0-10 ° C after solid precipitation, filter, rinse the solid with butanone (600 mL) 3 times, and then vacuum dry at 40 ± 5 ° C for 4-6 h to obtain a white solid as the compound of formula I 210.8 g, yield: 86.32%, purity: 99.93%, diastereoisomer (impurity I): 0.02%, impurity A: 0.02%, impurities B, C, D, E, F, G, H were not detected.
[0131] The formoterol fumarate prepared in Example 6 was subjected to high performance liquid chromatography. High performance chromatograph, Agilent 1260I detector VWD, chromatographic column Agilent zorbax SB-C8, 150*4.6mm, 5μm; phosphate buffer (3.73g of sodium dihydrogen phosphate monohydrate was taken, 1000ml of water was added to dissolve it, and phosphoric acid was added to adjust the pH value to 3.3) as mobile phase A, acetonitrile as mobile phase B, and gradient elution was performed. The specific conditions are as follows:
[0132] Time (min) Mobile phase A Mobile phase B (%) 0 () 16 10 84 16 37 30 70 40 84 16 55 84 16
[0133] The detection wavelength is 214 nm; the flow rate is 1.0 mL / min; the column temperature is 30 °C, see Figure 2 The test results are shown in Table 1 below:
[0134] Table 1 HPLC analysis of impurity A and formoterol fumarate
[0135]
[0136]
[0137] The formoterol fumarate prepared in Example 6 was subjected to high performance liquid chromatography. High performance chromatograph, Agilent 1260I detector VWD, chromatographic column Shodex Asahipak ODP-50 4D, 150*4.6 mm, 5 μm; acetonitrile: potassium sulfate buffer (12:88) as mobile phase; detection wavelength of 225 nm; flow rate: 0.5 mL / min; column temperature of 30°C, see Figure 3 ; System suitability data is available at Figure 4 ; The test results are shown in Table 2 below:
[0138] Table 2 HPLC analysis of impurity I and formoterol fumarate
[0139]
[0140] The formoterol fumarate prepared in Example 6 was subjected to accelerated and long-term stability tests. Accelerated stability: Test drug stability test box (Yongsheng SHH-5005D), storage conditions: 40°C ± 2°C, 75% ± 5% RH; Long-term stability: Test drug stability test box (Yongsheng SHH-5005D), storage conditions: 25°C ± 2°C, 60% ± 5% RH, the results are detailed in Tables 3 and 4 below.
[0141] Table 3 Accelerated stability data statistics
[0142]
[0143]
[0144] Conclusion: After 6 months of accelerated testing, the properties, moisture content, specific rotation, melting point, related substances, content and isomers of the refined formoterol fumarate sample did not change significantly compared with the 0-month sample, and met the requirements.
[0145] Table 4 Long-term stability test data
[0146]
[0147]
[0148] Conclusion: After 12 months of long-term testing, the properties, moisture content, specific rotation, melting point, related substances, content and isomers of the refined formoterol fumarate sample did not change significantly compared with the 0-month sample, and met the requirements.
[0149] Comparative Example 1
[0150] The experiment was carried out with reference to Example 1, except that in step 3) step a) fumaric acid (32.7 g) and ethylene glycol (210 mL) were added until the viscous substance was completely dissolved. The final yield of the compound of formula V was 85.03%, the purity was 98.32%, and the diastereomer was 0.10%.
[0151] From this example, it can be seen that when ethylene glycol is used as the organic solvent A, the yield of the compound of formula V obtained is higher, but the purity is relatively low and the diastereoisomer removal effect is poor.
[0152] Comparative Example 2
[0153] The experiment was carried out with reference to Example 1, except that 3) step a): the internal temperature was further lowered to -20 to -10°C, and the mixture was stirred for crystallization for 1-2 hours. The final yield of the compound of formula V was 82.14%, the purity was 98.91%, and the diastereomer was 0.09%.
[0154] The experiment was carried out with reference to Example 1, except that 3) step a): the internal temperature was further lowered to 20 to 30°C, and the mixture was stirred for crystallization for 1-2 hours. The final yield of the compound of formula V was 79.22%, the purity was 99.92%, and the diastereomer was 0.04%.
[0155] As can be seen from this example, when the crystallization temperature is between -20 and -10°C, the purity of the compound of formula V obtained is poor and the isomer removal effect is not good. When the crystallization temperature is between 20 and 30°C, the yield of the compound of formula V obtained is low.
[0156] Comparative Example 3
[0157] The experiment was carried out with reference to Example 1, except that in step 3) step c) the yellow oil (115 g) obtained in step b) and acetonitrile (920 mL) were added to the reaction flask, and the final compound of formula V had a yield of 85.27%, a purity of 97.88%, and a diastereoisomer of 0.15%.
[0158] As can be seen from this example, when acetonitrile is used as the organic solvent C, the yield of the compound of formula V obtained is very high, but the purity is low and the diastereoisomer removal effect is poor.
[0159] Comparative Example 4
[0160] The experiment was carried out in accordance with Example 1, except that in step 5), the reaction solution was pressed out with nitrogen and filtered, the reaction flask and the filter cake were washed with a mixed solution of methanol (150 mL) and ethyl acetate (150 mL), and the filtrate was concentrated and evaporated under reduced pressure in a water bath at 40-50°C to obtain a compound of formula VII with a yield of 81.11%, a purity of 99.15%, diastereoisomers of 0.02%, impurity A of 0.12%, impurity F of 0.10%, and impurities B, C, D, E, G, and H were not detected.
[0161] It can be seen from this example that when the concentration temperature is 40-50°C, the impurities in the compound of formula VII are significantly higher.
[0162] Comparative Example 5
[0163] The experiment was carried out in accordance with Example 1, except that in step 5) the filtrate was concentrated and evaporated under reduced pressure in a water bath at 30-35°C for less than 4 hours with a vacuum degree greater than -0.09 MPa, and then n-hexane (300 mL) and methanol (10 mL) were added with stirring and slurrying for 3-4 hours. The solid was filtered to obtain a solid, which was washed three times with n-hexane (60 mL) to obtain a compound of formula VII with a yield of 85.56%, a purity of 98.00%, diastereoisomers of 0.03%, impurity A of 0.11%, impurity F of 0.09%, and impurities B, C, D, E, G, and H were not detected.
[0164] As can be seen from this embodiment, when n-hexane is used as the organic solvent D, the yield of the compound of formula VII is high, the purity is low, and the impurity content is relatively high.
[0165] Comparative Example 6
[0166] The experiment was carried out with reference to Example 1, except that in step 5) the filtrate was concentrated and evaporated under reduced pressure in a water bath at 30-35°C for less than 4 hours with a vacuum degree greater than -0.09 MPa, and then dichloromethane (300 mL) and ethyl acetate (10 mL) were added with stirring and slurrying for 3-4 hours. The solid was filtered to obtain a solid, and the solid was washed three times with dichloromethane (60 mL) to obtain a compound of formula VII with a yield of 70.99%, a purity of 99.94%, diastereoisomers of 0.02%, impurity A of 0.02%, and impurities B, C, D, E, F, G, and H were not detected.
[0167] From this example, it can be seen that when ethyl acetate is used as the organic solvent F, the yield of the compound of formula VII is relatively low.
[0168] Comparative Example 7
[0169] The experiment was carried out in accordance with Example 1, with the only difference being that in step 5), n-hexane (300 mL) and methanol (10 mL) were further added, stirred, slurried for 3-4 h, filtered to obtain a solid, and the solid was washed three times with n-hexane (60 mL) to obtain a compound of formula VII with a yield of 85.77%, a purity of 98.33%, diastereoisomers of 0.03%, impurity A of 0.13%, impurity F of 0.08%, and impurities B, C, D, E, G, and H were not detected.
[0170] It can be seen from this embodiment that when n-hexane is used as solvent E, the purity of the compound of formula VII is low and the impurities are high.
[0171] Comparative Example 8
[0172] The experiment was carried out in accordance with Example 1, except that in step 5), dichloromethane (300 mL) and dimethyl sulfoxide (10 mL) were added and stirred, and the mixture was slurried for 3-4 h. The solid was filtered to obtain a solid, and the solid was washed three times with dichloromethane (60 mL) to obtain a compound of formula VII with a yield of 72.12%, a purity of 99.91%, diastereoisomers of 0.03%, impurity A of 0.03%, and impurities B, C, D, E, F, G, and H were not detected.
[0173] It can be seen from this example that when dimethyl sulfoxide is used as solvent F, the yield of the compound of formula VII is relatively low.
[0174] Comparative Example 9
[0175] The compound of formula V (A) (250 g) obtained in step 2) of Example 1 and isopropyl ether (2000 mL) were added to a reaction flask, heated to 50-60°C, stirred to dissolve, and after complete dissolution, the internal temperature was slowly lowered to 20-30°C, and the internal temperature was maintained at 20-30°C. After stirring for 2-3 hours, no solid was precipitated. After stirring for 20 hours, solid was precipitated. The solid was filtered to obtain a solid, and the solid was washed three times with isopropyl ether (250 mL), and then vacuum dried at 50±5°C for 4-6 hours to obtain 32 g of compound of formula V as a white solid. The yield was relatively low, the purity was 97.6%, and the non-corresponding isomers were 0.05%.
[0176] As can be seen from this example, the compound of formula V (A) is obtained without salt formation, and is directly crystallized from isopropyl ether. The product is difficult to crystallize and has low purity.
[0177] Comparative Example 10
[0178] The compound of formula VI (60 g) obtained in step 4) of Example 1, 10% palladium on carbon (12.0 g), methanol (360 mL) and ethyl acetate (360 mL) were added to the reaction bottle, stirring was started, nitrogen was passed into the hydrogenation kettle three times, each time until the pressure reached 0.50-0.52 MPa, and hydrogen was then passed into the hydrogenation kettle three times, each time until the pressure reached 0.50-0.52 MPa. Under the condition of hydrogen gas passing to a pressure of 0.50-0.52MPa, heat to 30-35°C, stir for 4-5h until the reaction is complete (HPLC detection, calculated by normalization method based on peak area, impurity H <1.0%, the reaction is considered complete), then remove the pressure, replace once with nitrogen gas 0.2-0.3MPa, press out the reaction solution with nitrogen, filter, wash the reaction flask and filter cake with a mixed solution of methanol (150mL) and ethyl acetate (150mL), and concentrate the filtrate under reduced pressure and evaporate in a water bath at 30-35°C for less than 4h, with a vacuum degree greater than -0.09MPa. After the solvent is concentrated to dryness, methanol (600mL) and dimethyl sulfoxide (DMSO) (80mL) are directly added to the reaction flask. At 20-30°C, fumaric acid (6.7 g) and methanol (200 mL) were added, stirred to dissolve, and after the solid was dissolved, stirred for 10 min, water (80 mL) and butanone (800 mL) were added, and the temperature was lowered to 0-10°C. After solid precipitation, it was stirred for 2-3 h at 0-10°C, filtered, and the solid was rinsed with butanone (180 mL) 3 times, and then vacuum dried at 40±5°C for 4-6 h to obtain 27.6 g of a white solid compound of formula I, with a yield of 70.35%, a purity of 98.33%, diastereomers (impurity I): 0.02%, impurity A: 0.28%, impurity F: 0.21%, and impurities B, C, D, E, G, and H were not detected.
[0179] As can be seen from this embodiment, the compound of formula I is prepared after post-treatment and concentration, and is directly salified without purification. The obtained compound of formula I has low purity and high impurities.
[0180] Comparative Example 11
[0181] Formoterol fumarate was prepared according to the method disclosed in WO2008 / 035380A2 in the background technology, specifically as follows:
[0182] 1) Preparation of 2-{benzyl-[2-(4-methoxyphenyl)-1-methylethyl]amino}-1-(4-benzyloxy-3-nitrophenyl)-ethanol (Formula IV)
[0183] To a 5L four-necked flask, add 188g (0.358mol) of 2-{benzyl-{2-4-methoxyphenyl)-1-methylethyl]amino}-1-(4-benzyloxy-3-nitrophenyl)-ethanone (X) and 2.5L of methanol. At RT (25-30°C), add 10 equal portions of 35g (0.921mol) of sodium borohydride to the stirred reaction solution. After addition, stir the resulting solution at 25-30°C overnight. After rotary evaporation of methanol, dissolve the resulting residue in toluene (2.0L) and wash with water (2.5L). Then stir the toluene solution with activated carbon and filter. Concentrate under reduced pressure to remove toluene to obtain 205g of compound IV as a yellow oil. HPLC purity: RR and SS isomers: 50.21%; RS and SR isomers: 44.43%.
[0184] Purification of compound of formula IV:
[0185] The above oily compound (205 g) was added to a 2L four-necked flask and ground with isopropyl ether (1200 mL) at room temperature (25-30°C) overnight. A yellow solid (110 g) was obtained by filtration. The solid compound was further purified by recrystallization with isopropyl ether (650 mL) at 25-30°C to obtain 80 g of yellow crystals of the compound of formula IV. HPLC purity: RR and SS isomers: >96.46%; RS and SR isomers: <3.54%.
[0186] 2) Preparation of 1-(3-amino-4-benzyloxyphenyl)-2-{benzyl-[2-(4-methoxyphenyl)-1-methylethyl]amino}ethanol (V)
[0187] Add the nitro alcohol derivative of formula Ⅳ (15 g) and methanol (500 mL) to a 2L stainless steel hydrogenation reactor, protect with nitrogen, and add Raney nickel catalyst (3-5 g) (previously washed with methanol) to the solution. Then introduce hydrogen and hydrogenate at 40-60 psi H2 pressure and RT (25-30°C). After the hydrogenation is completed, filter to remove the catalyst under nitrogen, and concentrate the filtrate under reduced pressure to remove the solvent to obtain a brown-yellow compound as a crude product of formula V (10.9 g). HPLC purity: RR and SS isomers: 97.74%, RS and SR isomers: 0.79%
[0188] Purification of compound of formula V:
[0189] At 65-70°C, the crude product (10.9 g) was dissolved in isopropyl ether (54.5 mL), activated carbon was added, stirred and filtered, and the filtrate was slowly cooled to room temperature (25-30°C) and filtered to obtain brown-yellow crystals of compound V (8.7 g). MR: 97.5-99.5°C, HPLC purity: RR and SS isomers: 97.85%, RS and SR isomers: 0.64%
[0190] 3) Preparation of N-[5-(2-{benzyl[2-(4-methoxyphenyl)-1-methylethyl]amino}-1-hydroxyethyl)-2-benzyloxyphenyl] (VI)
[0191] Acetic anhydride (31.52 g) was added to a 1L four-necked flask and cooled to 0°C with a cooling bath. Under vigorous stirring, formic acid (15.96 mL) was added dropwise at a rate of about 1 mL / min to keep the temperature of the reaction mixture below 5°C. After 30 minutes, the reaction solution was heated to 50-55°C. After 2 hours, the reaction solution was cooled to 5-10°C. A THF (260 mL) solution of a pre-dissolved crystalline amino derivative of formula V (42 g) was added to the solution at 5-10°C. After the addition, the cooling bath was removed and the reaction was stirred at room temperature overnight. The solvent was removed by concentrating under reduced pressure, and the oily residue was dissolved in ethyl acetate and washed successively with a 5% aqueous sodium bicarbonate solution and a sodium carbonate solution. The organic layer was stirred with activated carbon and then filtered to obtain a clear solution. The solvent was removed by concentrating under reduced pressure and crystallized with isopropyl ether to obtain 42.0 g of a crystalline compound of formula VI. The product was recrystallized from isopropanol (420 mL) at 25-30°C to obtain 40.2 g of white crystalline compound of formula VI. MR: 112.7-114.2°C, HPLC purity: RR and SS isomers: 98.07%, RS and SR isomers: 0.56%, acetylated impurities: 1.5%.
[0192] 4) Preparation of N-(2-hydroxy-5-{1-hydroxy-2-[2-(4-methoxyphenyl)-1-methylethylamino]ethyl}phenylcarboxamide VII
[0193] A solution of the pre-dissolved crystalline compound of formula VI (40 g) in ethyl acetate (250 mL) was added to a 1L stainless steel hydrogenation reactor. A suspension of 10% palladium on carbon (16 g) in methanol (250 mL) was added to the solution. The mixture was hydrogenated at 40-60 psi. After the hydrogenation was completed, the catalyst was filtered out under nitrogen, and the filtrate was concentrated under reduced pressure at 30-40°C to remove the solvent. The obtained compound was added with ethyl acetate (350 mL) and then isopropanol (250 mL) at 35-40°C, and crystallized at 30-35°C to obtain 15 g of the compound of formula VII as a white solid. HPLC purity: RR and SS: 99.13%, RS and SR isomers: 0.29%, impurity "A": 0.23%, impurity "C": 0.19%, impurity "F": 0.07%, impurity "E": 0.04%, and the remaining impurities B, D, G, and H were not detected.
[0194] 5) Preparation of Formoterol Fumarate Ι (B)
[0195] Add the above white solid formula VII (15 g) and toluene (150 mL) to a 500 mL four-necked flask. Add a pre-dissolved isopropanol (30 mL) solution of fumaric acid (2.40 g) to the stirred suspension at room temperature (25-30 ° C). After stirring for 5 hours at room temperature, filter, stir the resulting material with 95% isopropanol aqueous solution (300 ml), heat to 65-75 ° C, keep for 1-2 hours, then cool the reaction mass to 40-45 ° C, keep for 1-2 hours, and filter. Put the wet product into a flask, add acetonitrile (460 mL) and stir, and heat to 75-80 ° C. Keep for 1-2 hours, then cool the reactant to 40-45 ° C, keep for 1-2 hours, filter, and vacuum dry at 60 ° C to obtain 10.1 g of I (B) compound. HPLC purity: RR and SS: 99.08%, RS and SR isomers: 0.26%, impurity "A": 0.29%, impurity "C": 0.17%, impurity "F": 0.15%, impurity "E": 0.02%, the remaining impurities B, D, G, H were not detected.
[0196] 6) Preparation of Formoterol Fumarate Dihydrate Ι(C)
[0197] The above compound of formula I (B) (10.1 g) was ground with water (64 mL) for 30 minutes at RT (25-30° C.), then filtered, the wet cake was washed with water, and then vacuum dried at 60° C. to obtain 10.0 g of the compound of formula I (C) as a white solid. HPLC purity: 99.15%, impurity "A": 0.23%, impurity "C": 0.16%, impurity "F": 0.14%, impurity "E": 0.02%, and the remaining impurities B, D, G, and H were not detected. Isomer purity (HPLC): RR and SS: 99.10%, RS and SR isomers: 0.28%.
[0198] From the above preparation process, it can be seen that multiple crystallizations and high temperature conditions are used in the entire preparation process, and the operation is cumbersome; the preparation purity of formoterol VII is low, and multiple impurities are detected, which requires multiple purifications later, increasing the production cost; the preparation of Ι(B) is carried out under high temperature conditions, resulting in poor product stability and obvious growth of impurities; Ι(C) has the risk of losing crystal water when vacuum dried at 60°C.
[0199] The above embodiments are only preferred technical solutions of the present invention and should not be regarded as limiting the present invention. The embodiments and features in the embodiments of the present application can be arbitrarily combined with each other without conflict. The protection scope of the present invention shall be the technical solutions recorded in the claims, including the equivalent replacement solutions of the technical features in the technical solutions recorded in the claims, that is, equivalent replacement improvements within this scope are also within the protection scope of the present invention.
Claims
1. A method for preparing formoterol represented by formula VII, the method comprising the following steps: i) subjecting the compound represented by formula V and anhydrous formic acid to a formylation reaction in the presence of a condensing agent and an organic solvent G, followed by crystallization to obtain a compound represented by formula VI; ii) subjecting the compound represented by formula VI to a reduction reaction in the presence of a catalyst and an organic solvent H to obtain a crude formoterol; The method further comprises the following purification steps: 1) Pressing out the crude formoterol with nitrogen, filtering, and washing with an organic solvent D; 2) concentrating and evaporating the filtrate obtained in step 1) under reduced pressure; 3) adding organic solvent E and organic solvent F to the product obtained by evaporation in step 2), stirring and slurrying to obtain formoterol; In step 1), the organic solvent D is a mixed solution of methanol and ethyl acetate, methanol, ethanol or tetrahydrofuran; In step 2), the reduced pressure concentration and evaporation is carried out in a water bath at 30-40°C; In step 3), the organic solvent E is dichloromethane, 1,2-dichloroethane or chloroform; the organic solvent F is methanol, ethanol or isopropanol.
2. The method according to claim 1, characterized in that In step 1), the organic solvent D is a mixed solution of methanol and ethyl acetate.
3. The method according to claim 1, characterized in that In step 2), the reduced pressure concentration and evaporation is carried out in a water bath at 30° C.-35° C.
4. The method according to any one of claims 1 to 3, characterized in that In step 3), the organic solvent E is dichloromethane.
5. The method according to any one of claims 1 to 3, characterized in that In step 3), the organic solvent F is methanol.
6. The method according to any one of claims 1 to 3, characterized in that In step 3), the volume ratio between the organic solvent E and the organic solvent F is 20:1-30:
1.
7. The method according to any one of claims 1 to 3, characterized in that In step 3), the volume ratio between the organic solvent E and the organic solvent F is 25:1-30:
1.
8. The method according to any one of claims 1 to 3, characterized in that In step i), the condensing agent is 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride, 2-(7-benzotriazole oxide)-N,N,N',N'-tetramethyluronium hexafluorophosphate or dicyclohexylcarbodiimide.
9. The method according to claim 8, characterized in that In step i), the condensing agent is 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride.
10. The method according to any one of claims 1 to 3, characterized in that In step i), the organic solvent G is selected from one or more of dichloromethane, 1,2-dichloroethane, chloroform and ethyl acetate.
11. The method according to claim 10, characterized in that In step i), the organic solvent G is dichloromethane or 1,2-dichloroethane.
12. The method according to claim 10, characterized in that In step i), the organic solvent G is dichloromethane.
13. The method according to any one of claims 1 to 3, characterized in that In step ii), the catalyst is 5w / w%-10w / w% palladium on carbon or Raney nickel.
14. The method according to claim 13, characterized in that In step ii), the catalyst is 5 w / w% to 10 w / w% palladium on carbon.
15. The method according to claim 13, characterized in that In step ii), the catalyst is 10 w / w% palladium on carbon.
16. The method according to any one of claims 1 to 3, characterized in that In step ii), the organic solvent H is a mixed solution of methanol and ethyl acetate, methanol, ethanol or tetrahydrofuran.
17. The method according to claim 16, characterized in that In step ii), the organic solvent H is a mixed solution of methanol and ethyl acetate.
18. The method according to any one of claims 1 to 3, characterized in that In step i), the compound represented by formula V is prepared by the following method: I) allowing a crude compound of formula V and fumaric acid to undergo a salt-forming reaction in an organic solvent A to prepare a fumarate of the compound of formula V; II) subjecting the fumarate of the compound represented by formula V obtained in step I) to a neutralization reaction with a base in an organic solvent B to obtain a purified compound represented by formula V; III) The purified compound of formula V obtained in step II) is crystallized in an organic solvent C to obtain a formoterol intermediate.
19. The method according to claim 18, characterized in that In step I), the organic solvent A is ester and alcohol.
20. The method according to claim 18, characterized in that In step I), the organic solvent A is ethyl acetate and alcohol.
21. The method according to claim 18, characterized in that In step I), the organic solvent A is ethyl acetate and a lower alkanol; the lower alkanol is methanol or ethanol.
22. The method according to claim 18, characterized in that In step I), the preparation method of the fumarate salt of the compound represented by formula V is as follows: Heat the crude compound of formula V and ethyl acetate to 60-75°C, then add fumaric acid and alcohol, stir to dissolve, and after complete dissolution, cool to 20-35°C, stir for 1-2h, continue to cool to -10-20°C, stir and crystallize for 1-2h to obtain the product.
23. The method according to claim 18, characterized in that In step I), the preparation method of the fumarate salt of the compound represented by formula V is as follows: Heat the crude compound of formula V and ethyl acetate to 70-75°C, then add fumaric acid and alcohol, stir to dissolve, and after complete dissolution, cool to 20-30°C, stir for 1-2h, continue to cool to 0-10°C, stir and crystallize for 1-2h to obtain the product.
24. The method according to claim 19 or 20, characterized in that In step I), the alcohol in the organic solvent A is selected from one or more of methanol, ethanol and isopropanol.
25. The method according to claim 24, characterized in that In step I), the alcohol in the organic solvent A is methanol or ethanol.
26. The method according to claim 24, characterized in that In step I), the alcohol in the organic solvent A is methanol.
27. The method according to claim 18, characterized in that In step II), the preparation method of the purified compound represented by formula V is as follows: The fumarate of the compound represented by formula V obtained in step I) and a base are heated in an organic solvent B to an internal temperature of 20-40° C. and stirred for reaction for 4-6 hours to obtain the product.
28. The method according to claim 18, characterized in that In step II), the preparation method of the purified compound represented by formula V is as follows: The fumarate of the compound represented by formula V obtained in step I) and a base are heated in an organic solvent B to an internal temperature of 30-40° C. and stirred for reaction for 4-6 hours to obtain the product.
29. The method according to claim 18, characterized in that In step II), the organic solvent B is dichloromethane, ethyl acetate or acetonitrile.
30. The method according to claim 29, characterized in that In step II), the organic solvent B is dichloromethane or ethyl acetate.
31. The method according to claim 29, characterized in that In step II), the organic solvent B is dichloromethane.
32. The method according to claim 18, characterized in that In step II), the base is a 10 w / v%-20 w / v% sodium carbonate solution or a 10 w / v%-20 w / v% potassium carbonate solution.
33. The method according to claim 18, characterized in that In step II), the base is a 10 w / v% to 20 w / v% sodium carbonate solution.
34. The method according to claim 18, characterized in that In step II), the base is a 10 w / v% sodium carbonate solution.
35. The method according to claim 18, characterized in that In step III), the preparation method of the formoterol intermediate is as follows: The purified compound of formula V obtained in step II) is heated to 50-70° C. in an organic solvent C, stirred and dissolved, and after being completely dissolved, the internal temperature is slowly lowered to 15-35° C., stirred and crystallized for 2-3 hours, to obtain the formoterol intermediate.
36. The method according to claim 18, characterized in that In step III), the preparation method of the formoterol intermediate is as follows: The purified compound of formula V obtained in step II) is heated to 60-70° C. in an organic solvent C, stirred and dissolved, and after being completely dissolved, the internal temperature is slowly lowered to 20-30° C., stirred and crystallized for 2-3 hours to obtain a formoterol intermediate.
37. The method according to claim 18, characterized in that In step III), the organic solvent C is 50 v / v% ethanol, ethyl acetate or isopropyl ether.
38. The method according to claim 37, characterized in that In step III), the organic solvent C is 50 v / v% ethanol or isopropyl ether.
39. The method according to claim 37, characterized in that In step III), the organic solvent C is isopropyl ether.
40. The method according to claim 37, characterized in that In step III), the ratio between the purified compound of formula V obtained in step II) and the solvent C is 1 g:8.0 mL to 1 g:15.0 mL.
41. The method according to claim 40, characterized in that In step III), the ratio between the purified compound of formula V obtained in step II) and the solvent C is 1 g:10.0 mL to 1 g:12.0 mL.
42. A method for preparing formoterol fumarate represented by formula I, the method comprising the following steps: The compound represented by formula VII and fumaric acid are reacted to form a salt in the presence of methanol, dimethyl sulfoxide, an organic solvent I and water, and then crystallized to obtain; in, The organic solvent I is acetone, dichloromethane, butanone, ethyl acetate or acetonitrile; It also includes the step of preparing the compound represented by formula VII by the method described in any one of claims 1 to 41.
43. The method according to claim 42, characterized in that The organic solvent I is butanone, ethyl acetate or acetonitrile.
44. The method according to claim 42, characterized in that The organic solvent I is butanone.
Citation Information
Patent Citations
N-hydroxyphenyl formamide deriv. prepn.
ES2005492A6
{60 -Aminomethylbenzyl alcohol derivatives
US3994974A
An improved process for the preparation of high purity formoterol and its pharmaceutically acceptable salts
WO2008035380A2
IN201503548I3
